| Computational investigations of three main drugs and their comparison with synthesized compounds as potent inhibitors of SARS-CoV-2 main protease (Mpro): DFT, QSAR, molecular … RK Mohapatra, L Perekhoda, M Azam, M Suleiman, AK Sarangi, ... Journal of King Saud University-Science 33 (2), 101315, 2021 | 76 | 2021 |
| Synthesis, docking, and biological evaluation of novel 1-benzyl-4-(4-(R)-5-sulfonylidene-4, 5-dihydro-1H-1, 2, 4-triazol-3-yl) pyrrolidin-2-ones as potential nootropic agents AP Semenets, MM Suleiman, AI Fedosov, SY Shtrygol, IO Havrylov, ... European Journal of Medicinal Chemistry 244, 114823, 2022 | 10 | 2022 |
| Theoretical justification of a purposeful search of potential neurotropic drugs A Semenets, M Suleiman, SM Kovalenko, V Georgiyants, M Pokrovskii, ... ScienceRise: Pharmaceutical Science 4 (26), 4-17, 2020 | 5 | 2020 |
| Prediction of antitumor activity of 3-substituted quinazolinone derivatives synthesized in one-pot method catalyzed by Bi (OTf) 3 L Perekhoda, M Krishna, T Sekhar, A Venkateswarlu, P Thriveni, ... | 1 | 2022 |
| Synthesis and docking studies of new 1-benzyl-4-(4-(R)-5-sulfonylidene-4, 5-dihydro-1H-1, 2, 4-triazol-3-yl) pyrrolidin-2-ones as potential nootropic agents A Semenets, M Suleiman, L Perekhoda | 1 | 2021 |
| The use of molecular docing for the rational design of new" drug-like" molecules SV Vedeniev, AP Semenets, MM Suleiman, LO Perekhoda | 1 | 2020 |
| Synthesis and prediction of nootropic activity of substituted 4-(aminomethyl)-1-benzylpyrrolidin-2-ones A Semenets, M Suleiman, L Grinevich, N Kobzar, S Kovalenko, ... | | 2021 |
| Synthesis of new 2, 5-disubstituted derivatives of 1, 3, 4-thiadiazole, containing 1, 2, 4-triazole fragment MY Zaari, IV Sych, AP Semenets, MM Suleiman, LO Perekhoda | | 2020 |
| The use of the molecular docking to establish the possible mechanism of the anticonvulsant action of 5-R-2-(r1-amino)-1, 3, 4-thiadiazole derivatives AP Semenets, MM Suleiman | | 2019 |
